Nanophoria Bioscience
CONTACT
  • About us
    • About NanoPhoria
    • Team
    • Investors
  • Therapeutic focus
  • Our Platform
    • Drug Delivery Platform
    • Pipeline
    • Background Science
  • Clinical Programs
    • NP-MP1
  • News
    • Press releases

Month: January 2024

NanoPhoria appoints Dr Suman Shirodkar as chair and Prof. Michael Davidson as non-executive member of the Board of Directors

Posted on 8 January 20249 February 2026 by fowlerat
Posted in Press Release

NanoPhoria Bioscience publishes groundbreaking study in major cardiology journal

Posted on 2 January 202410 February 2026 by fowlerat
Posted in Press Release

Recent Posts

  • BioCentury Emerging Company Profile
  • NanoPhoria Awarded Second-Place Prize in INNLIFES’ “I Protagonisti Dell’innovazione 2026” Contest
  • European Biotechnology 2026 European Start-ups to Watch
  • NanoPhoria Announces Second Close of its Series A Round, Now with Participation from European Innovation Council Fund 
  • Scrip Asks 2026

Recent Comments

No comments to show.

Archives

  • June 2026
  • May 2026
  • March 2026
  • January 2026
  • December 2025
  • October 2025
  • February 2025
  • January 2024
  • November 2022
  • June 2022
  • May 2022

Categories

  • In the Media
  • Press Release
Connect with us
Learn more about our company and the science behind our revolutionary technology platform
Get in touch
Terms of use
Privacy Policy
Cookies

© NanoPhoria S.r.l. All rights reserved.
VAT number: 12246020965